• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病及其并发症的计算机建模:胡德山挑战赛第四次会议报告

Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting.

出版信息

Diabetes Care. 2007 Jun;30(6):1638-46. doi: 10.2337/dc07-9919.

DOI:10.2337/dc07-9919
PMID:17526823
Abstract

Computer simulation models are mathematical equations combined in a structured framework to represent some real or hypothetical system. One of their uses is to allow the projection of short-term data from clinical trials to evaluate clinical outcomes and costs over a long-term period. This technology is becoming increasingly important to assist decision making in modern medicine in situations where there is a paucity of long-term clinical trial data, as recently acknowledged in the American Diabetes Association Consensus Panel Guidelines for Computer Modeling of Diabetes and its Complications. The Mount Hood Challenge Meetings provide a forum for computer modelers of diabetes to discuss and compare models and identify key areas of future development to advance the field. The Fourth Mount Hood Challenge in 2004 was the first meeting of its kind to ask modelers to perform simulations of outcomes for patients in published clinical trials, allowing comparison against "real life" data. Eight modeling groups participated in the challenge. Each group was given three of the following challenges: to simulate a trial of type 2 diabetes (CARDS [Collaborative Atorvastatin Diabetes Study]); to simulate a trial of type 1 diabetes (DCCT [Diabetes Control and Complications Trial]); and to calculate outcomes for a hypothetical, precisely specified patient (cross-model validation). The results of the models varied from each other and for methodological reasons, in some cases, from the published trial data in important ways. This approach of performing systematic comparisons and validation exercises has enabled the identification of key differences among the models, as well as their possible causes and directions for improvement in the future.

摘要

计算机模拟模型是在结构化框架中组合的数学方程,用于表示某些真实或假设的系统。其用途之一是允许从临床试验中预测短期数据,以评估长期的临床结果和成本。在长期临床试验数据匮乏的情况下,这项技术对于协助现代医学决策变得越来越重要,正如美国糖尿病协会糖尿病及其并发症计算机建模共识小组指南最近所承认的那样。胡德山挑战会议为糖尿病计算机建模人员提供了一个论坛,用于讨论和比较模型,并确定未来发展的关键领域,以推动该领域的发展。2004年的第四届胡德山挑战会议是同类会议中的首次会议,要求建模人员对已发表临床试验中患者的结果进行模拟,以便与“现实生活”数据进行比较。八个建模小组参与了此次挑战。每个小组都面临以下三项挑战中的三项:模拟2型糖尿病试验(CARDS[阿托伐他汀协作糖尿病研究]);模拟1型糖尿病试验(DCCT[糖尿病控制与并发症试验]);以及计算一名假设的、精确指定的患者的结果(跨模型验证)。由于方法学原因,模型的结果彼此不同,在某些情况下,与已发表的试验数据在重要方面也存在差异。这种进行系统比较和验证练习的方法能够识别模型之间的关键差异,以及它们可能的原因和未来改进的方向。

相似文献

1
Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting.糖尿病及其并发症的计算机建模:胡德山挑战赛第四次会议报告
Diabetes Care. 2007 Jun;30(6):1638-46. doi: 10.2337/dc07-9919.
2
Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.糖尿病及其并发症的计算机建模:第五届胡德山挑战赛会议报告。
Value Health. 2013 Jun;16(4):670-85. doi: 10.1016/j.jval.2013.01.002. Epub 2013 Apr 18.
3
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.糖尿病的计算机建模及其透明度:第八届胡德山挑战赛报告。
Value Health. 2018 Jun;21(6):724-731. doi: 10.1016/j.jval.2018.02.002. Epub 2018 Apr 9.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Computer modeling of diabetes and its complications: a report on the fifth mount hood challenge meeting.糖尿病及其并发症的计算机建模:关于第五届胡德山挑战赛会议的报告
Value Health. 2013 Jun;16(4):453-4. doi: 10.1016/j.jval.2013.04.003.
6
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge.评估糖尿病经济模型模拟新型心血管结局试验的能力:第九次胡德山糖尿病挑战赛报告。
Value Health. 2020 Sep;23(9):1163-1170. doi: 10.1016/j.jval.2020.04.1832. Epub 2020 Aug 6.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.核心糖尿病模型:预测1型和2型糖尿病干预措施的长期临床结局、成本及成本效益,以支持临床和报销决策。
Curr Med Res Opin. 2004 Aug;20 Suppl 1:S5-26. doi: 10.1185/030079904X1980.
9
Diabetes and bone health.糖尿病与骨骼健康。
Diabetes Self Manag. 2008 Mar-Apr;25(2):11-2, 14.
10
Economic Simulation Modeling in Type 2 Diabetes.2 型糖尿病的经济模拟建模。
Curr Diab Rep. 2020 May 17;20(7):24. doi: 10.1007/s11892-020-01306-y.

引用本文的文献

1
Cardiovascular Risk Prediction Scores in Type 1 Diabetes: A Systematic Review and Meta-Analysis.1型糖尿病的心血管风险预测评分:一项系统评价和荟萃分析
JACC Adv. 2024 Dec 17;4(1):101462. doi: 10.1016/j.jacadv.2024.101462. eCollection 2025 Jan.
2
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
3
Using QALYs as an Outcome for Assessing Global Prediction Accuracy in Diabetes Simulation Models.
使用质量调整生命年作为评估糖尿病模拟模型全球预测准确性的结果指标。
Med Decis Making. 2025 Jan;45(1):45-59. doi: 10.1177/0272989X241285866. Epub 2024 Oct 30.
4
5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine.替尔泊肽或司美格鲁肽对比甘精胰岛素治疗人群的糖尿病相关并发症 5 年模拟研究。
Diabetes Obes Metab. 2024 Feb;26(2):463-472. doi: 10.1111/dom.15332. Epub 2023 Oct 22.
5
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus.新型非胰岛素抗糖尿病药物成本效益研究的系统评价:用于模拟 2 型糖尿病的决策分析模型的趋势。
Pharmacoeconomics. 2023 Nov;41(11):1469-1514. doi: 10.1007/s40273-023-01268-5. Epub 2023 Jul 6.
6
Prediction of complications in health economic models of type 2 diabetes: a review of methods used.预测 2 型糖尿病健康经济模型中的并发症:方法综述。
Acta Diabetol. 2023 Jul;60(7):861-879. doi: 10.1007/s00592-023-02045-8. Epub 2023 Mar 3.
7
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge.阿尔茨海默病和相关痴呆症的成本效益模型:IPECAD 建模研讨会交叉比较挑战。
Alzheimers Dement. 2023 May;19(5):1800-1820. doi: 10.1002/alz.12811. Epub 2022 Oct 25.
8
A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DM.提交给英国国家卫生与临床优化研究所技术评估项目的用于治疗1型糖尿病和2型糖尿病的经济模型综述
Front Pharmacol. 2022 May 11;13:887298. doi: 10.3389/fphar.2022.887298. eCollection 2022.
9
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.探索健康状态效用值在糖尿病经济模拟模型中的结构不确定性及其对终生结局的影响:来自第九次胡德山糖尿病生活质量挑战赛的结果。
Med Decis Making. 2022 Jul;42(5):599-611. doi: 10.1177/0272989X211065479. Epub 2021 Dec 15.
10
Use of Imputation and Decision Modeling to Improve Diagnosis and Management of Patients at Risk for New-Onset Diabetes After Transplantation.利用插补和决策模型改善移植后新发糖尿病风险患者的诊断和管理。
Ann Transplant. 2021 Mar 16;26:e928624. doi: 10.12659/AOT.928624.